WeedMD closes its fund-raising with full exercise of the over-allotment option

In all, 16.05mln units were sold at a price of $2.15 each.
Canadian dollars
WeedMD raised C$34.5mln (gross) from the issue

WeedMD Inc (CVE:WMD), a producer and distributor of medical cannabis, has closed its short form prospectus offering, including the full exercise of the over-allotment option.

In all, 16.05mln units were sold at a price of $2.15 each.

READ WeedMD increases size of its equity financing​

Each unit consists of a share and a half a warrant; the two halves of a warrant together entitle the holder to purchase a WeedMD common share at C$2.90 anytime before 11 January, 2020.

WeedMD shares currently trade at C$2.35, down 22 cents on the day.

The company intends to use the net proceeds of the offering to expand its lease footprint and retrofitting plans and operations at its 14-acre Strathroy Greenhouse; to purchase and further develop its Aylmer Facility; to pursue potential strategic domestic and international opportunities; and for working capital and general corporate purposes.

View full WMD profile View Profile

WeedMD Timeline

Related Articles

February 22 2018
The company is developing its medical cannabis for both domestic and global markets

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright © personabelovo.ru, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated.